The practice at Simmons & Simmons assists well-known clients spanning industry sectors from biotech and chemistry, to TMT. Atop the team’s non-contentious capabilities in matters including portfolio management and prosecution, the team is also equipped to handle litigious cases and advise on the IP aspects of commercial transactions. Electronics and medical devices specialist Kevin Cordina oversees the offering, while Frederick Nicolle handles prosecution and litigious matters in the chemistry and life sciences sectors, in particular.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The IP team at Simmons & Simmons' London office are first-class. Experienced advisors who put the interest of their clients first and advise with a commercial mind.'
- 'The team members come with different industry background and work very well together.'
- 'Kevin Cordina is a calm and experienced professional who covers all aspects of IP.'
- 'Frederick Nicolle is an experienced professional with deep knowledge in certain areas. Their thought process is global and commercial.'
Key clients
- Danaher
- Solventum
- Apple
- Enoda
- Natura Cosmeticos
- Haemochromatosis UK
- Celanese
- Axovia Therapeutics
- Okipa
- Varonis
- Toyota
- Surf Security
Work highlights
Conducted significant contentious projects for the client.
Advising Okipa across the breadth of their business.
Advised Solventum after their spin-out from 3M and displaced their incumbent provider to become their preferred attorneys for drafting new patent applications.
Practice head
Kevin Cordina
Other key lawyers
Frederick Nicolle